The conversation is about expecting results from Breezula, a hairloss treatment, with no new information released as of April 1st. Some joked it's just onion juice, while another comment suggested a conspiracy to cause baldness.
A user's experience with microneedling monotherapy and potential treatments such as finasteride, minoxidil, Stemoxydine, rosemary oil, peppermint oil, and RU58841 for reversing hairloss.
Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hairloss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.
A 23-year-old is self-conscious about a receding hairline and is considering using finasteride and minoxidil to regrow or thicken hair. Advice suggests consulting a doctor, as finasteride can stop hairloss and minoxidil can promote regrowth, but expectations should be realistic, especially for hairline regrowth.
A 21-year-old with a family history of early balding is advised to see a dermatologist to confirm androgenetic alopecia (AGA) and consider treatments like finasteride or dutasteride to prevent further hairloss, and minoxidil, possibly with tretinoin, to regrow hair. Caution is advised with oral minoxidil, and a cardiologist should be consulted before use.
People discussed using finasteride, minoxidil, and dutasteride for hairloss, with mixed results and side effects. Some had positive outcomes, while others experienced issues like libido changes and chose alternatives like hair systems.
Androgenic alopecia (AGA) might have evolved to reduce prostate cancer risk by increasing UV exposure to the scalp, but this theory is debated. Treatments like minoxidil and finasteride are used for AGA, though the exact causes and evolutionary reasons for hairloss are unclear.
A new alcohol-free, propylene glycol-free topical finasteride foam is available for prescription in Canada and the USA, offering a cleaner alternative for hairloss treatment. The product also offers a combination of 0.1% finasteride with 5% minoxidil and aims to be affordable and less irritating for sensitive scalps.
Pelage secured $120 million for PP405, a non-hormonal topical hairloss treatment, sparking debate on its potential as a breakthrough. Concerns about finasteride's side effects persist, with some suggesting alternatives like topical finasteride or dutasteride.